Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.3 trillion and total revenue of $115.84 billion.
Market Cap
1.3T
Revenue
115.84B
Profits
-38.16B
PE Ratio
n/a
Profit Margin
-32.94%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 133.37B | 0.73% | 756,167 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 79.40B | 2.08% | 13,963,886 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 78.69B | -1.00% | 592,145 | 15.53B |
| 4 | ARGX | argenx SE | 60.24B | -0.28% | 264,371 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 43.93B | 2.56% | 2,520,486 | - |
| 6 | ONC | BeOne Medicines AG | 41.03B | 0.24% | 377,176 | 6.13B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 34.25B | 2.55% | 1,084,464 | 4.80B |
| 8 | RPRX | Royalty Pharma plc | 33.47B | -0.14% | 1,869,475 | 2.54B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.86B | -0.91% | 6,764,416 | 7.53M |
| 10 | INSM | Insmed Incorporated | 25.73B | -3.06% | 2,672,745 | 1.14B |
| 11 | INCY | Incyte Corporation | 25.11B | -0.44% | 1,210,055 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.75B | -0.75% | 579,956 | 3.03B |
| 13 | GMAB | Genmab A/S | 20.74B | 1.41% | 3,583,181 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.45B | 0.71% | 1,129,593 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 14.82B | -2.21% | 419,970 | 1.20B |
| 16 | EXEL | Exelixis, Inc. | 14.41B | 0.36% | 1,989,678 | 2.44B |
| 17 | HALO | Halozyme Therapeutics, Inc. | 12.93B | -1.15% | 1,958,264 | 1.66B |
| 18 | BBIO | BridgeBio Pharma, Inc. | 12.82B | -1.07% | 1,998,852 | 713.07M |
| 19 | CORT | Corcept Therapeutics Incorporated | 12.55B | -2.03% | 800,796 | 830.81M |
| 20 | SMMT | Summit Therapeutics Inc. | 12.45B | -4.70% | 3,807,975 | - |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.93B | 0.65% | 153,392 | 1.28B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 11.66B | -1.78% | 1,791,424 | 3.41B |
| 23 | TWST | Twist Bioscience Corporation | 11.46B | -0.65% | 2,694,348 | 431.80M |
| 24 | TECH | Bio-Techne Corporation | 11.39B | 0.06% | 2,175,955 | 1.22B |
| 25 | KRYS | Krystal Biotech, Inc. | 10.24B | 0.25% | 199,918 | 440.48M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 10.22B | -0.48% | 838,177 | 776.57M |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.31B | -0.23% | 1,616,163 | 669.50M |
| 28 | KYMR | Kymera Therapeutics, Inc. | 9.31B | -3.33% | 698,433 | 105.00M |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 9.18B | 3.29% | 809,192 | 281.99M |
| 30 | CAI | Caris Life Sciences, Inc. | 9.04B | -0.90% | 2,919,183 | 989.61M |
| 31 | CYTK | Cytokinetics, Incorporated | 8.99B | -1.52% | 1,599,215 | 67.67M |
| 32 | IBRX | ImmunityBio, Inc. | 8.95B | -2.31% | 5,819,350 | 165.79M |
| 33 | PCVX | Vaxcyte, Inc. | 8.36B | -1.21% | 947,290 | - |
| 34 | TGTX | TG Therapeutics, Inc. | 8.15B | -0.16% | 1,309,361 | 799.54M |
| 35 | ABVX | ABIVAX Société Anonyme | 8.14B | -4.02% | 1,484,591 | 5.33M |
| 36 | PRAX | Praxis Precision Medicines, Inc. | 7.84B | -0.36% | 456,242 | 7.46M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 7.56B | -1.61% | 560,049 | - |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 7.40B | 1.57% | 6,202,218 | 874.09M |
| 39 | IMVT | Immunovant, Inc. | 6.88B | -2.06% | 2,349,999 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.79B | 0.36% | 864,251 | 239.92M |
| 41 | BLTE | Belite Bio, Inc | 6.74B | -1.25% | 123,704 | - |
| 42 | LGND | Ligand Pharmaceuticals Incorporated | 6.01B | 0.83% | 305,796 | 290.54M |
| 43 | CGON | CG Oncology, Inc. | 5.95B | -2.34% | 1,177,484 | 6.23M |
| 44 | SRRK | Scholar Rock Holding Corporation | 5.92B | 0.04% | 1,875,797 | - |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 5.82B | 0.38% | 765,796 | 618.07M |
| 46 | COGT | Cogent Biosciences, Inc. | 5.61B | 2.80% | 2,979,048 | - |
| 47 | TVTX | Travere Therapeutics, Inc. | 5.60B | -1.95% | 1,205,901 | 591.33M |
| 48 | ORKA | Oruka Therapeutics, Inc. | 5.59B | -1.20% | 499,721 | - |
| 49 | CRSP | CRISPR Therapeutics AG | 5.24B | -2.64% | 1,008,897 | 13.39M |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.23B | 0.63% | 1,203,027 | 1.01B |
| 51 | ERAS | Erasca, Inc. | 4.98B | -1.86% | 3,218,053 | - |
| 52 | IOVA | Iovance Biotherapeutics, Inc. | 4.98B | 1.85% | 12,633,884 | 324.97M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.95B | -2.38% | 522,723 | 1.90M |
| 54 | MANE | Veradermics, Incorporated | 4.87B | 0.73% | 613,621 | - |
| 55 | DFTX | Definium Therapeutics, Inc. | 4.86B | -1.52% | 2,682,917 | - |
| 56 | EWTX | Edgewise Therapeutics, Inc. | 4.27B | -4.42% | 2,487,516 | - |
| 57 | TNGX | Tango Therapeutics, Inc. | 4.20B | 1.18% | 3,254,999 | 53.81M |
| 58 | VKTX | Viking Therapeutics, Inc. | 4.15B | -3.24% | 13,617,271 | - |
| 59 | ABCL | AbCellera Biologics Inc. | 4.12B | 0.40% | 3,383,868 | 66.17M |
| 60 | CELC | Celcuity Inc. | 3.89B | 0.19% | 657,162 | - |
| 61 | PBLS | Parabilis Medicines, Inc. | 3.85B | -3.91% | 1,119,022 | 148.00K |
| 62 | RLAY | Relay Therapeutics, Inc. | 3.83B | -1.47% | 2,983,626 | 10.35M |
| 63 | TLX | Telix Pharmaceuticals Limited | 3.79B | 1.24% | 409,202 | 890.79M |
| 64 | LEGN | Legend Biotech Corporation | 3.70B | 0.26% | 1,428,328 | 1.27B |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.58B | -2.94% | 2,433,747 | 7.50M |
| 66 | ACAD | Acadia Pharmaceuticals Inc. | 3.56B | -6.76% | 3,364,113 | 1.14B |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.54B | - | 487,199 | 234.13M |
| 68 | ARQT | Arcutis Biotherapeutics, Inc. | 3.38B | 2.47% | 2,039,975 | 463.98M |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.32B | -0.36% | 721,440 | 606.33M |
| 70 | ELVN | Enliven Therapeutics, Inc. | 3.28B | -0.93% | 963,786 | - |
| 71 | DNLI | Denali Therapeutics Inc. | 3.26B | -0.39% | 1,257,677 | 3.60M |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.18B | -0.36% | 1,717,332 | 117.00M |
| 73 | DYN | Dyne Therapeutics, Inc. | 2.99B | -2.91% | 1,612,918 | - |
| 74 | ZLAB | Zai Lab Limited | 2.80B | -1.19% | 299,900 | 449.61M |
| 75 | PGEN | Precigen, Inc. | 2.77B | 0.65% | 6,563,526 | 85.72M |
| 76 | NAMS | NewAmsterdam Pharma Company N.V. | 2.70B | -0.70% | 1,135,990 | 7.12M |
| 77 | QURE | uniQure N.V. | 2.65B | -0.23% | 1,176,583 | 18.67M |
| 78 | MBX | MBX Biosciences, Inc. | 2.58B | -3.18% | 563,528 | - |
| 79 | GPCR | Structure Therapeutics Inc. | 2.56B | -0.25% | 1,587,795 | - |
| 80 | IRON | Disc Medicine, Inc. | 2.50B | -1.81% | 427,231 | - |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.44B | -1.21% | 2,023,886 | 158.00K |
| 82 | IMNM | Immunome, Inc. | 2.43B | -4.16% | 2,421,626 | 4.02M |
| 83 | BEAM | Beam Therapeutics Inc. | 2.43B | -1.58% | 1,219,342 | 156.04M |
| 84 | HRMY | Harmony Biosciences Holdings, Inc. | 2.40B | 0.24% | 556,855 | 959.90M |
| 85 | NRIX | Nurix Therapeutics, Inc. | 2.39B | -2.71% | 1,540,070 | 36.77M |
| 86 | VERA | Vera Therapeutics, Inc. | 2.34B | -2.40% | 1,250,478 | - |
| 87 | SLS | SELLAS Life Sciences Group, Inc. | 2.34B | -3.09% | 4,452,916 | - |
| 88 | VRDN | Viridian Therapeutics, Inc. | 2.32B | -0.92% | 2,090,645 | 71.13M |
| 89 | MLYS | Mineralys Therapeutics, Inc. | 2.29B | -2.75% | 1,192,717 | - |
| 90 | PHVS | Pharvaris N.V. | 2.25B | -2.94% | 597,497 | - |
| 91 | AUPH | Aurinia Pharmaceuticals Inc. | 2.19B | -0.96% | 734,401 | 311.51M |
| 92 | OCUL | Ocular Therapeutix, Inc. | 2.12B | -1.73% | 1,621,483 | 52.06M |
| 93 | ADMA | ADMA Biologics, Inc. | 2.10B | -1.47% | 3,566,524 | 512.28M |
| 94 | ADRX | ADARx Pharmaceuticals, Inc. | 2.06B | 13.82% | 4,213,818 | 6.13M |
| 95 | TRVI | Trevi Therapeutics, Inc. | 2.05B | -1.84% | 1,364,962 | - |
| 96 | VCEL | Vericel Corporation | 2.03B | 1.04% | 359,896 | 306.30M |
| 97 | KOD | Kodiak Sciences Inc. | 2.03B | -2.62% | 2,277,335 | - |
| 98 | URGN | UroGen Pharma Ltd. | 2.02B | 0.29% | 655,313 | 188.73M |
| 99 | NUVB | Nuvation Bio Inc. | 2.02B | 0.17% | 2,817,201 | 169.90M |
| 100 | RXRX | Recursion Pharmaceuticals, Inc. | 2.01B | -3.86% | 10,481,051 | 54.86M |
| 101 | PVLA | Palvella Therapeutics, Inc. | 1.99B | -5.42% | 193,341 | - |
| 102 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.97B | -0.65% | 1,930,861 | 208.78M |
| 103 | SRPT | Sarepta Therapeutics, Inc. | 1.97B | 1.52% | 2,218,839 | 1.97B |
| 104 | MESO | Mesoblast Limited | 1.97B | -2.33% | 126,080 | 120.25M |
| 105 | BHVN | Biohaven Ltd. | 1.96B | -1.52% | 1,579,106 | - |
| 106 | NKTR | Nektar Therapeutics | 1.95B | -3.91% | 2,636,128 | 54.59M |
| 107 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | -0.97% | 996,512 | 98.34M |
| 108 | GENB | Generate Biomedicines, Inc. | 1.94B | -5.25% | 1,266,989 | 26.48M |
| 109 | LKFT | Lakefront Biotherapeutics NV | 1.92B | -3.23% | 250,700 | 1.13B |
| 110 | FTRE | Fortrea Holdings Inc. | 1.89B | -0.65% | 708,894 | 2.68B |
| 111 | ZYME | Zymeworks Inc. | 1.88B | -1.08% | 1,094,727 | 37.13M |
| 112 | VIR | Vir Biotechnology, Inc. | 1.80B | -0.56% | 1,125,948 | 303.23M |
| 113 | XNCR | Xencor, Inc. | 1.77B | -0.34% | 1,169,669 | 104.97M |
| 114 | SEPN | Septerna, Inc. | 1.76B | -0.94% | 344,294 | 98.88M |
| 115 | ZBIO | Zenas BioPharma, Inc. | 1.76B | -2.00% | 747,843 | 1.00M |
| 116 | NVAX | Novavax, Inc. | 1.75B | 0.28% | 3,910,299 | 413.80M |
| 117 | NBTX | Nanobiotix S.A. | 1.69B | -0.45% | 124,575 | 13.15M |
| 118 | ABSI | Absci Corporation | 1.67B | -5.89% | 3,206,563 | 1.56M |
| 119 | NTLA | Intellia Therapeutics, Inc. | 1.65B | -3.37% | 2,985,547 | 59.51M |
| 120 | GHRS | GH Research PLC | 1.64B | -2.49% | 179,976 | - |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.63B | 0.24% | 711,805 | 20.00M |
| 122 | SNDX | Syndax Pharmaceuticals, Inc. | 1.63B | 1.28% | 1,343,101 | 252.25M |
| 123 | COAG | Hemab Therapeutics Holdings, Inc. | 1.62B | -2.74% | 266,529 | - |
| 124 | STOK | Stoke Therapeutics, Inc. | 1.60B | -1.94% | 1,218,091 | 27.59M |
| 125 | IMCR | Immunocore Holdings plc | 1.58B | -1.82% | 271,894 | 430.78M |
| 126 | ANAB | AnaptysBio, Inc. | 1.52B | -1.35% | 437,400 | 106.09M |
| 127 | TSHA | Taysha Gene Therapies, Inc. | 1.52B | -2.51% | 4,660,849 | 5.49M |
| 128 | INVA | Innoviva, Inc. | 1.50B | 0.44% | 623,372 | 440.00M |
| 129 | TYRA | Tyra Biosciences, Inc. | 1.50B | -2.90% | 1,421,982 | - |
| 130 | INBX | Inhibrx Biosciences, Inc. | 1.47B | -0.79% | 158,658 | 1.30M |
| 131 | KLRA | Kailera Therapeutics, Inc. | 1.45B | -6.39% | 1,722,736 | - |
| 132 | OMER | Omeros Corporation | 1.45B | -0.25% | 941,896 | 38.42M |
| 133 | MAZE | Maze Therapeutics, Inc. | 1.45B | -0.61% | 925,606 | 20.00M |
| 134 | RARE | Ultragenyx Pharmaceutical Inc. | 1.43B | -1.83% | 4,306,057 | 717.00M |
| 135 | KRSA | Korsana Biosciences, Inc. | 1.41B | -16.64% | 34,777 | - |
| 136 | AVBP | ArriVent BioPharma, Inc. | 1.40B | -5.48% | 653,151 | - |
| 137 | KARD | Kardigan, Inc. | 1.38B | 2.78% | 628,912 | - |
| 138 | ORIC | ORIC Pharmaceuticals, Inc. | 1.36B | -0.15% | 2,493,809 | - |
| 139 | AAPG | Ascentage Pharma Group International | 1.36B | -2.46% | 2,864 | 94.61M |
| 140 | BRVE | Braveheart Bio, Inc. | 1.35B | -11.77% | 471,826 | - |
| 141 | DRTS | Alpha Tau Medical Ltd. | 1.34B | -1.56% | 435,363 | - |
| 142 | DMRA | Damora Therapeutics, Inc. | 1.28B | 1.92% | 1,431,775 | - |
| 143 | BCAX | Bicara Therapeutics Inc. | 1.27B | -2.88% | 662,512 | - |
| 144 | SVRA | Savara Inc. | 1.27B | -1.38% | 2,451,630 | - |
| 145 | AVLN | Avalyn Pharma Inc. | 1.24B | -1.65% | 223,122 | - |
| 146 | TRAX | First Tracks Biotherapeutics, Inc. | 1.23B | -3.94% | 356,510 | - |
| 147 | LBRX | LB Pharmaceuticals Inc | 1.20B | -1.24% | 398,941 | - |
| 148 | REPL | Replimune Group, Inc. | 1.16B | -1.90% | 1,647,235 | - |
| 149 | SPTX | Seaport Therapeutics, Inc. | 1.15B | 1.89% | 192,796 | - |
| 150 | IMTX | Immatics N.V. | 1.14B | 0.48% | 378,808 | 47.65M |
| 151 | LTGO | Latigo Biotherapeutics, Inc. | 1.14B | -3.43% | 275,688 | - |
| 152 | VOR | Vor Biopharma Inc. | 1.10B | 0.43% | 792,829 | - |
| 153 | AKTS | Aktis Oncology, Inc. | 1.08B | -1.02% | 518,910 | 10.06M |
| 154 | MNKD | MannKind Corporation | 1.07B | 1.52% | 8,853,613 | 393.63M |
| 155 | MGTX | MeiraGTx Holdings plc | 1.05B | -1.27% | 1,555,566 | 397.50M |
| 156 | ANRO | Alto Neuroscience, Inc. | 1.04B | -2.54% | 366,263 | - |
| 157 | MLTX | MoonLake Immunotherapeutics | 1.02B | -0.66% | 2,179,618 | - |
| 158 | GLUE | Monte Rosa Therapeutics, Inc. | 1.00B | 0.43% | 802,136 | 28.73M |
| 159 | ANL | Adlai Nortye Group Ltd. | 1.00B | -0.88% | 34,799 | 18.06M |
| 160 | JANX | Janux Therapeutics, Inc. | 996.53M | -2.28% | 720,162 | 24.00M |
| 161 | ODTX | Odyssey Therapeutics, Inc. | 982.81M | 2.91% | 237,781 | 99.00K |
| 162 | CRVS | Corvus Pharmaceuticals, Inc. | 977.49M | -1.53% | 1,099,643 | - |
| 163 | ABUS | Arbutus Biopharma Corporation | 959.56M | -0.61% | 16,881,131 | 181.72M |
| 164 | KURA | Kura Oncology, Inc. | 957.22M | -0.92% | 1,226,674 | 77.23M |
| 165 | CGEM | Cullinan Therapeutics, Inc. | 953.09M | -4.08% | 1,715,490 | - |
| 166 | HELP | Cybin Inc. | 921.29M | 0.16% | 805,498 | - |
| 167 | ALMS | Alumis Inc. | 918.99M | -2.61% | 1,723,930 | 7.40M |
| 168 | JBIO | Jade Biosciences, Inc. | 917.07M | -2.10% | 525,819 | - |
| 169 | SGP | SpyGlass Pharma, Inc. | 905.44M | -2.10% | 96,408 | - |
| 170 | RIGL | Rigel Pharmaceuticals, Inc. | 900.00M | 0.61% | 204,927 | 276.79M |
| 171 | SLBT | SL Science Holding Limited | 895.32M | 0.64% | 286,681 | 3.27M |
| 172 | SANA | Sana Biotechnology, Inc. | 881.62M | -0.51% | 2,880,332 | - |
| 173 | APMD | Apnimed, Inc. | 877.99M | -2.50% | 298,550 | 115.12M |
| 174 | ARDX | Ardelyx, Inc. | 852.22M | -0.87% | 2,126,078 | 450.89M |
| 175 | CADL | Candel Therapeutics, Inc. | 843.23M | -4.59% | 799,697 | - |
| 176 | AVTX | Avalo Therapeutics, Inc. | 829.66M | -1.59% | 1,433,791 | 59.00K |
| 177 | ATTO | Attovia Therapeutics, Inc. | 811.68M | -2.15% | 404,431 | 1.80M |
| 178 | GERN | Geron Corporation | 809.52M | - | 10,302,741 | 204.56M |
| 179 | FDMT | 4D Molecular Therapeutics, Inc. | 799.38M | -1.63% | 1,017,950 | 92.01M |
| 180 | LXRX | Lexicon Pharmaceuticals, Inc. | 798.70M | -3.49% | 3,050,414 | 41.47M |
| 181 | OBX | Obsidian Therapeutics, Inc. | 794.40M | -4.10% | 454,476 | - |
| 182 | IMMX | Immix Biopharma, Inc. | 784.79M | -6.24% | 1,828,421 | - |
| 183 | SLDB | Solid Biosciences Inc. | 781.67M | -2.54% | 1,420,481 | - |
| 184 | GYRE | Gyre Therapeutics, Inc. | 779.35M | 0.27% | 134,831 | 109.82M |
| 185 | ACHV | Achieve Life Sciences, Inc. | 775.88M | -3.70% | 1,422,933 | - |
| 186 | IVA | Inventiva S.A. | 766.06M | 3.37% | 2,998,590 | 7.94M |
| 187 | OLMA | Olema Pharmaceuticals, Inc. | 765.60M | -3.21% | 1,382,733 | - |
| 188 | DSGN | Design Therapeutics, Inc. | 758.49M | -0.98% | 434,470 | - |
| 189 | ACRS | Aclaris Therapeutics, Inc. | 758.07M | -4.28% | 1,474,036 | 8.22M |
| 190 | PHAR | Pharming Group N.V. | 747.87M | 0.19% | 128,516 | 366.48M |
| 191 | WVE | Wave Life Sciences, Inc. | 744.84M | -4.55% | 4,066,700 | 65.37M |
| 192 | ETRA | Electra Therapeutics, Inc. | 724.96M | -2.28% | 438,362 | - |
| 193 | FTH | Faeth Therapeutics, Inc. | 723.53M | -3.61% | 328,188 | - |
| 194 | DNA | Ginkgo Bioworks Holdings, Inc. | 717.85M | 4.00% | 2,312,318 | 132.42M |
| 195 | VSTM | Verastem, Inc. | 700.96M | -0.77% | 1,061,072 | 87.53M |
| 196 | ANNX | Annexon, Inc. | 690.07M | -4.21% | 3,510,757 | - |
| 197 | DBVT | DBV Technologies S.A. | 681.87M | -0.34% | 289,997 | 5.04M |
| 198 | MDXG | MiMedx Group, Inc. | 680.70M | -0.85% | 1,460,099 | 355.17M |
| 199 | SLN | Silence Therapeutics plc | 673.14M | -0.36% | 953,220 | 615.00K |
| 200 | OABI | OmniAb, Inc. | 670.25M | -3.76% | 783,590 | 38.46M |
| 201 | CLYM | Climb Bio, Inc. | 669.71M | -1.93% | 1,532,843 | - |
| 202 | NVCT | Nuvectis Pharma, Inc. | 658.80M | -6.52% | 191,813 | - |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 655.60M | -1.95% | 678,556 | 136.07M |
| 204 | BLSM | BlossomHill Therapeutics, Inc. | 627.75M | -3.52% | 203,053 | - |
| 205 | AURA | Aura Biosciences, Inc. | 622.23M | -2.44% | 1,116,376 | - |
| 206 | CRMD | CorMedix Inc. | 611.86M | 1.03% | 606,642 | 462.25M |
| 207 | STTK | Shattuck Labs, Inc. | 609.20M | -3.80% | 893,670 | 1.00M |
| 208 | CBIO | Crescent Biopharma, Inc. | 598.79M | -1.76% | 228,645 | 11.88M |
| 209 | ALT | Altimmune, Inc. | 595.22M | 0.66% | 2,859,131 | 31.00K |
| 210 | CTMX | CytomX Therapeutics, Inc. | 588.33M | -1.82% | 3,031,502 | 18.30M |
| 211 | MPLT | MapLight Therapeutics, Inc. | 581.32M | -2.79% | 317,495 | - |
| 212 | PHAT | Phathom Pharmaceuticals, Inc. | 579.84M | 3.11% | 1,442,495 | 239.66M |
| 213 | VALN | Valneva SE | 574.88M | -1.29% | 15,036 | 163.30M |
| 214 | SGMT | Sagimet Biosciences Inc. | 574.35M | 1.43% | 1,246,944 | - |
| 215 | OCS | Oculis Holding AG | 572.26M | -1.49% | 239,582 | 1.45M |
| 216 | MNPR | Monopar Therapeutics Inc. | 572.11M | -4.06% | 105,822 | - |
| 217 | ALLO | Allogene Therapeutics, Inc. | 570.06M | -1.20% | 3,622,311 | 4.64M |
| 218 | NGNE | Neurogene Inc. | 566.52M | -9.41% | 200,066 | 925.00K |
| 219 | EPRX | Eupraxia Pharmaceuticals Inc. | 527.23M | -1.84% | 1,313,299 | - |
| 220 | AGMB | AgomAb Therapeutics NV | 517.60M | -0.66% | 164,025 | - |
| 221 | PRME | Prime Medicine, Inc. | 515.92M | -5.54% | 7,116,280 | 4.07M |
| 222 | DRUG | Bright Minds Biosciences Inc. | 515.74M | -3.20% | 210,970 | - |
| 223 | INDP | Indaptus Therapeutics, Inc. | 512.98M | -3.75% | 570,879 | - |
| 224 | PBYI | Puma Biotechnology, Inc. | 504.33M | -0.51% | 261,775 | 231.24M |
| 225 | ARVN | Arvinas, Inc. | 496.28M | -2.57% | 713,342 | 316.70M |
| 226 | AUTL | Autolus Therapeutics plc | 493.73M | -2.88% | 1,383,511 | 117.39M |
| 227 | RGNX | REGENXBIO Inc. | 488.50M | 2.21% | 1,276,586 | 174.48M |
| 228 | CAPR | Capricor Therapeutics, Inc. | 486.04M | -2.45% | 1,919,489 | 11.13M |
| 229 | PROK | ProKidney Corp. | 483.72M | -4.76% | 2,166,921 | 818.00K |
| 230 | ASMB | Assembly Biosciences, Inc. | 481.94M | 0.04% | 143,516 | 74.85M |
| 231 | ENTX | Entera Bio Ltd. | 475.27M | -1.96% | 776,301 | 42.00K |
| 232 | CTNM | Contineum Therapeutics, Inc. | 472.52M | 0.72% | 404,929 | - |
| 233 | OVID | Ovid Therapeutics Inc. | 468.71M | -3.81% | 1,364,814 | 1.58M |
| 234 | TECX | Tectonic Therapeutic, Inc. | 462.73M | -1.87% | 97,046 | - |
| 235 | EIKN | Eikon Therapeutics, Inc. | 428.99M | -4.46% | 377,185 | - |
| 236 | DMAC | DiaMedica Therapeutics Inc. | 428.17M | 1.40% | 236,352 | - |
| 237 | PRTA | Prothena Corporation plc | 425.58M | -0.22% | 481,047 | 54.53M |
| 238 | KYTX | Kyverna Therapeutics, Inc. | 421.15M | -2.58% | 1,503,217 | - |
| 239 | AVIR | Atea Pharmaceuticals, Inc. | 414.66M | - | 280,666 | - |
| 240 | RZLT | Rezolute, Inc. | 409.10M | -1.02% | 2,046,745 | - |
| 241 | RLMD | Relmada Therapeutics, Inc. | 408.55M | 0.52% | 1,311,049 | - |
| 242 | YDES | YD Bio Limited | 405.86M | 20.13% | 656,541 | 1.24M |
| 243 | SPRY | ARS Pharmaceuticals, Inc. | 405.75M | -1.69% | 1,035,223 | 116.93M |
| 244 | SCTX | Scribe Therapeutics Inc. | 402.87M | -1.53% | 458,653 | 33.30M |
| 245 | PRLD | Prelude Therapeutics Incorporated | 399.11M | -2.88% | 336,231 | 22.42M |
| 246 | EDIT | Editas Medicine, Inc. | 396.24M | -6.18% | 3,119,307 | 47.01M |
| 247 | IRD | Opus Genetics, Inc. | 396.01M | -2.26% | 1,244,932 | 9.86M |
| 248 | ARCT | Arcturus Therapeutics Holdings Inc. | 393.66M | -1.91% | 629,878 | 29.37M |
| 249 | GALT | Galectin Therapeutics Inc. | 393.31M | -1.52% | 124,516 | - |
| 250 | ZURA | Zura Bio Limited | 387.15M | -2.88% | 1,510,898 | - |
| 251 | AGEN | Agenus Inc. | 384.47M | 0.47% | 672,386 | 132.69M |
| 252 | VTVT | vTv Therapeutics Inc. | 375.35M | -1.69% | 28,732 | 36.84M |
| 253 | IKT | Inhibikase Therapeutics, Inc. | 375.07M | -1.90% | 447,227 | 1.00 |
| 254 | TTRX | Turn Therapeutics Inc. | 372.05M | -5.81% | 89,953 | - |
| 255 | FENC | Fennec Pharmaceuticals Inc. | 371.89M | -0.14% | 105,062 | 59.22M |
| 256 | CCCC | C4 Therapeutics, Inc. | 366.61M | -1.65% | 2,118,781 | 35.04M |
| 257 | OBIO | Orchestra BioMed Holdings, Inc. | 357.63M | - | 248,767 | 31.98M |
| 258 | CABA | Cabaletta Bio, Inc. | 350.96M | -3.94% | 3,097,086 | - |
| 259 | SRZN | Surrozen, Inc. | 347.20M | -12.29% | 1,929,420 | 11.51M |
| 260 | ENTA | Enanta Pharmaceuticals, Inc. | 346.01M | -1.00% | 217,266 | 65.26M |
| 261 | OCGN | Ocugen, Inc. | 345.89M | 2.00% | 8,694,535 | 4.58M |
| 262 | ARTV | Artiva Biotherapeutics, Inc. | 341.74M | -6.68% | 507,049 | 251.00K |
| 263 | VOGX | Vogenx, Inc. | 337.66M | -4.79% | 46,868 | - |
| 264 | BNTC | Benitec Biopharma Inc. | 334.53M | -0.52% | 106,965 | - |
| 265 | LRMR | Larimar Therapeutics, Inc. | 320.98M | -7.38% | 3,046,776 | - |
| 266 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 316.69M | -1.00% | 523,528 | - |
| 267 | EYPT | EyePoint, Inc. | 312.09M | -0.82% | 2,250,781 | 2.79M |
| 268 | ABEO | Abeona Therapeutics Inc. | 308.79M | -0.55% | 720,607 | 25.52M |
| 269 | EVMN | Evommune, Inc. | 308.12M | -3.52% | 542,051 | 10.00M |
| 270 | VNDA | Vanda Pharmaceuticals Inc. | 305.34M | 1.41% | 722,702 | 215.72M |
| 271 | IPSC | Century Therapeutics, Inc. | 302.40M | -1.18% | 456,958 | 109.16M |
| 272 | SABS | SAB Biotherapeutics, Inc. | 299.35M | -1.79% | 2,445,828 | 114.70K |
| 273 | XFOR | X4 Pharmaceuticals, Inc. | 298.43M | 0.33% | 1,856,551 | 15.85M |
| 274 | UPB | Upstream Bio, Inc. | 293.57M | 3.68% | 429,211 | 3.16M |
| 275 | FULC | Fulcrum Therapeutics, Inc. | 285.35M | -1.19% | 2,493,153 | 80.00M |
| 276 | RCKT | Rocket Pharmaceuticals, Inc. | 284.87M | -3.53% | 2,630,492 | - |
| 277 | CUVL | Clinuvel Pharmaceuticals Limited | 284.03M | -2.60% | 13,328 | 65.05M |
| 278 | FATE | Fate Therapeutics, Inc. | 281.58M | 0.86% | 3,387,239 | 6.49M |
| 279 | IFRX | InflaRx N.V. | 278.53M | -2.07% | 399,900 | -11.54K |
| 280 | IMRX | Immuneering Corporation | 276.26M | -1.61% | 513,394 | - |
| 281 | IVVD | Invivyd, Inc. | 275.36M | 2.29% | 3,514,891 | 58.37M |
| 282 | VCRE | Vicore Pharma Holding AB (publ) | 272.51M | -2.52% | 6,498 | 412.09K |
| 283 | LXEO | Lexeo Therapeutics, Inc. | 271.56M | -2.36% | 1,007,004 | - |
| 284 | GLSI | Greenwich LifeSciences, Inc. | 267.44M | 0.66% | 67,133 | - |
| 285 | STRO | Sutro Biopharma, Inc. | 264.97M | 1.72% | 292,050 | 45.70M |
| 286 | QTTB | Q32 Bio Inc. | 261.08M | -4.88% | 515,336 | 53.74M |
| 287 | LCTX | Lineage Cell Therapeutics, Inc. | 260.49M | 8.67% | 2,481,440 | 13.08M |
| 288 | BCYC | Bicycle Therapeutics plc | 257.92M | -1.21% | 238,875 | 61.21M |
| 289 | ZNTL | Zentalis Pharmaceuticals, Inc. | 255.61M | -1.82% | 1,067,400 | 26.87M |
| 290 | PALI | Palisade Bio, Inc. | 252.69M | -7.64% | 5,780,668 | 500.00K |
| 291 | ACIU | AC Immune SA | 250.56M | -5.26% | 323,578 | 21.67M |
| 292 | CAMP | Camp4 Therapeutics Corporation | 245.99M | 2.08% | 477,403 | 4.22M |
| 293 | LYEL | Lyell Immunopharma, Inc. | 241.38M | -2.67% | 108,900 | 27.00K |
| 294 | PYXS | Pyxis Oncology, Inc. | 238.55M | -2.05% | 609,741 | 11.04M |
| 295 | MGNX | MacroGenics, Inc. | 238.24M | -1.58% | 604,616 | 175.14M |
| 296 | YARW | Yarrow Bioscience, Inc. | 237.63M | -2.03% | 474,165 | - |
| 297 | SION | Sionna Therapeutics, Inc. | 236.46M | - | 1,402,272 | - |
| 298 | PRQR | ProQR Therapeutics N.V. | 232.85M | -3.51% | 584,788 | 21.05M |
| 299 | KROS | Keros Therapeutics, Inc. | 230.39M | 0.61% | 216,069 | 15.01M |
| 300 | CUE | Cue Biopharma, Inc. | 228.18M | -4.38% | 232,400 | 37.66M |
| 301 | CGEN | Compugen Ltd. | 225.44M | 0.42% | 77,724 | 74.00M |
| 302 | RNAC | Cartesian Therapeutics, Inc. | 224.19M | -2.76% | 158,586 | 1.48M |
| 303 | TRDA | Entrada Therapeutics, Inc. | 222.11M | -0.96% | 374,037 | 4.69M |
| 304 | AVXL | Anavex Life Sciences Corp. | 220.62M | 1.71% | 744,386 | - |
| 305 | PLX | Protalix BioTherapeutics, Inc. | 219.15M | -1.09% | 386,025 | 80.62M |
| 306 | SLGL | Sol-Gel Technologies Ltd. | 218.87M | 10.06% | 26,065 | 1.80M |
| 307 | ALEC | Alector, Inc. | 217.73M | 1.56% | 1,024,559 | 13.86M |
| 308 | ELDN | Eledon Pharmaceuticals, Inc. | 215.55M | -1.12% | 619,743 | - |
| 309 | WHWK | Whitehawk Therapeutics, Inc. | 213.21M | -3.11% | 166,980 | 7.15M |
| 310 | NGEN | NervGen Pharma Corp. | 208.59M | -3.96% | 343,192 | - |
| 311 | FHTX | Foghorn Therapeutics Inc. | 207.85M | -2.78% | 525,374 | 36.74M |
| 312 | CNTN | Canton Strategic Holdings, Inc. | 204.78M | 11.26% | 1,527,701 | 1.50M |
| 313 | CMPX | Compass Therapeutics, Inc. | 203.50M | -0.44% | 3,532,924 | 850.00K |
| 314 | VRXA | Veraxa Biotech AG | 199.39M | - | 55,691 | 29.54K |
| 315 | NKTX | Nkarta, Inc. | 196.97M | -3.51% | 681,083 | - |
| 316 | ORMP | Oramed Pharmaceuticals Inc. | 196.76M | -1.25% | 177,849 | 2.00M |
| 317 | ADAG | Adagene Inc. | 196.73M | -1.68% | 197,661 | 9.29M |
| 318 | TARA | Protara Therapeutics, Inc. | 193.83M | -2.09% | 552,923 | - |
| 319 | MSLE | Satellos Bioscience Inc. | 187.58M | -0.11% | 37,398 | - |
| 320 | ACOG | Alpha Cognition Inc. | 184.46M | -1.17% | 115,140 | 15.26M |
| 321 | ANTX | AN2 Therapeutics, Inc. | 184.15M | -0.20% | 155,127 | - |
| 322 | ALXO | ALX Oncology Holdings Inc. | 181.14M | -3.32% | 1,168,026 | - |
| 323 | PEPG | PepGen Inc. | 179.38M | -3.36% | 514,270 | - |
| 324 | MDWD | MediWound Ltd. | 178.68M | 0.18% | 72,570 | 11.86M |
| 325 | CHRS | Coherus Oncology, Inc. | 174.59M | -3.42% | 1,222,398 | 50.94M |
| 326 | DTIL | Precision BioSciences, Inc. | 171.68M | -1.74% | 203,967 | 45.06M |
| 327 | TNXP | Tonix Pharmaceuticals Holding Corp. | 169.11M | 1.65% | 380,561 | 29.10M |
| 328 | VYGR | Voyager Therapeutics, Inc. | 165.14M | -4.29% | 721,275 | 34.46M |
| 329 | NERV | Minerva Neurosciences, Inc. | 162.34M | -1.45% | 103,311 | - |
| 330 | ABOS | Acumen Pharmaceuticals, Inc. | 161.99M | 0.22% | 235,301 | - |
| 331 | NBP | NovaBridge Biosciences | 160.08M | -4.83% | 6,610,045 | - |
| 332 | OTLK | Outlook Therapeutics, Inc. | 155.68M | -2.49% | 2,936,198 | -1.16M |
| 333 | HUMA | Humacyte, Inc. | 154.82M | -2.00% | 2,619,713 | 2.12M |
| 334 | IPHA | Innate Pharma S.A. | 153.98M | -0.29% | 31,018 | 11.21M |
| 335 | MENS | Jyong Biotech Ltd. | 150.69M | -5.58% | 38,066 | - |
| 336 | MOLN | Molecular Partners AG | 148.83M | - | 24 | 856.30K |
| 337 | CDXS | Codexis, Inc. | 144.55M | -3.65% | 464,717 | 77.68M |
| 338 | RNA | Atrium Therapeutics, Inc. | 141.81M | 1.22% | 221,427 | 35.84M |
| 339 | KRRO | Korro Bio, Inc. | 140.92M | - | 114,418 | 2.38M |
| 340 | SPRB | Spruce Biosciences, Inc. | 140.02M | -0.43% | 37,188 | 697.00K |
| 341 | ARMP | Armata Pharmaceuticals, Inc. | 139.06M | 3.31% | 100,793 | 5.54M |
| 342 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 138.10M | -4.16% | 708,577 | - |
| 343 | TNYA | Tenaya Therapeutics, Inc. | 136.69M | -1.68% | 3,726,247 | 1.34M |
| 344 | HURA | TuHURA Biosciences, Inc. | 133.83M | - | 149,262 | - |
| 345 | CRBU | Caribou Biosciences, Inc. | 132.94M | -0.80% | 901,266 | 10.04M |
| 346 | ENGN | enGene Therapeutics Inc. | 131.35M | 2.08% | 1,976,101 | - |
| 347 | KZIA | Kazia Therapeutics Limited | 131.14M | -2.15% | 244,255 | 1.27M |
| 348 | UNCY | Unicycive Therapeutics, Inc. | 130.78M | -2.39% | 495,050 | - |
| 349 | TLSA | Tiziana Life Sciences Ltd | 130.60M | -2.88% | 382,693 | - |
| 350 | NRXP | NRx Pharmaceuticals, Inc. | 129.57M | -1.16% | 793,377 | 3.39M |
| 351 | IMUX | Immunic, Inc. | 127.51M | 0.27% | 316,740 | - |
| 352 | NMRA | Neumora Therapeutics, Inc. | 127.32M | -3.63% | 2,315,966 | - |
| 353 | MNOV | MediciNova, Inc. | 126.99M | -2.64% | 257,314 | 920.48K |
| 354 | LENZ | LENZ Therapeutics, Inc. | 123.01M | 5.24% | 923,776 | 21.48M |
| 355 | NAUT | Nautilus Biotechnology, Inc. | 122.51M | -2.81% | 681,680 | 190.00K |
| 356 | INO | Inovio Pharmaceuticals, Inc. | 122.01M | -2.48% | 2,252,632 | 65.34K |
| 357 | COYA | Coya Therapeutics, Inc. | 119.17M | -1.93% | 59,938 | 8.02M |
| 358 | OKUR | OnKure Therapeutics, Inc. | 117.44M | -1.02% | 91,423 | - |
| 359 | CBUS | Cibus, Inc. | 116.17M | 1.33% | 66,793 | 4.35M |
| 360 | TVGN | Tevogen Inc. | 114.09M | -7.64% | 5,561 | - |
| 361 | VANI | Vivani Medical, Inc. | 111.85M | 0.81% | 128,190 | - |
| 362 | GNLX | Genelux Corporation | 111.13M | 2.06% | 139,689 | 8.00K |
| 363 | MIST | Milestone Pharmaceuticals Inc. | 111.09M | -0.82% | 1,265,346 | 2.34M |
| 364 | AARD | Aardvark Therapeutics, Inc. | 110.74M | -8.83% | 71,472 | - |
| 365 | CNXU | Conexeu Sciences Inc. | 109.72M | -1.77% | 111,197 | - |
| 366 | BDTX | Black Diamond Therapeutics, Inc. | 108.01M | -0.53% | 378,800 | 70.00M |
| 367 | PYPD | PolyPid Ltd. | 106.03M | -2.61% | 44,766 | - |
| 368 | EQ | Equillium, Inc. | 105.89M | -2.91% | 137,728 | 4.39M |
| 369 | RANI | Rani Therapeutics Holdings, Inc. | 105.83M | 1.36% | 382,608 | 4.88M |
| 370 | SEER | Seer, Inc. | 105.76M | 2.14% | 244,108 | 14.22M |
| 371 | PLYX | Polaryx Therapeutics, Inc. | 104.18M | -2.34% | 12,407 | - |
| 372 | TENX | Tenax Therapeutics, Inc. | 103.68M | -4.23% | 1,997,253 | - |
| 373 | CLLS | Cellectis S.A. | 103.39M | 2.80% | 37,740 | 63.82M |
| 374 | PMN | ProMIS Neurosciences, Inc. | 101.07M | -2.59% | 19,962 | - |
| 375 | PMVP | PMV Pharmaceuticals, Inc. | 100.43M | -0.37% | 271,150 | - |
| 376 | NTRB | Nutriband Inc. | 97.25M | -11.01% | 409,989 | 1.62M |
| 377 | ACET | Adicet Bio, Inc. | 97.09M | 9.07% | 634,022 | - |
| 378 | ANIX | Anixa Biosciences, Inc. | 96.64M | - | 360,786 | - |
| 379 | CRDF | Cardiff Oncology, Inc. | 96.47M | -3.13% | 563,326 | 508.00K |
| 380 | BMEA | Biomea Fusion, Inc. | 95.68M | -11.41% | 3,083,456 | - |
| 381 | NRXS | NeurAxis, Inc. | 94.94M | -2.45% | 144,385 | 5.32M |
| 382 | ICCC | ImmuCell Corporation | 90.14M | -0.45% | 5,048 | 30.68M |
| 383 | ACRV | Acrivon Therapeutics, Inc. | 89.99M | -0.94% | 181,911 | - |
| 384 | CGTX | Cognition Therapeutics, Inc. | 89.06M | -1.50% | 540,018 | - |
| 385 | ATRA | Atara Biotherapeutics, Inc. | 88.43M | 3.16% | 31,197 | 6.19M |
| 386 | RLYB | Rallybio Corporation | 88.26M | 0.06% | 7,026 | 646.00K |
| 387 | ONCY | Oncolytics Biotech Inc. | 87.13M | 0.60% | 826,236 | - |
| 388 | PTHS | Pelthos Therapeutics Inc. | 84.95M | -0.94% | 14,850 | 43.30M |
| 389 | TELO | Telomir Pharmaceuticals, Inc. | 84.59M | 1.65% | 55,972 | - |
| 390 | NTHI | NeOnc Technologies Holdings, Inc. | 82.28M | 0.30% | 135,432 | 39.99K |
| 391 | GANX | Gain Therapeutics, Inc. | 77.69M | -3.26% | 383,022 | - |
| 392 | GUTS | Fractyl Health, Inc. | 77.30M | 3.34% | 3,264,721 | 3.00K |
| 393 | OSTX | OS Therapies Incorporated | 76.57M | - | 171,323 | - |
| 394 | IBIO | iBio, Inc. | 76.53M | -0.83% | 620,931 | 100.00K |
| 395 | FBIO | Fortress Biotech, Inc. | 76.04M | - | 264,884 | 68.47M |
| 396 | VRCA | Verrica Pharmaceuticals Inc. | 75.07M | 0.23% | 72,849 | 30.32M |
| 397 | RNXT | RenovoRx, Inc. | 74.91M | -1.19% | 490,570 | 1.98M |
| 398 | BSEM | BioStem Technologies, Inc. | 73.90M | 6.70% | 278,940 | 34.59M |
| 399 | MAIA | MAIA Biotechnology, Inc. | 72.99M | -4.00% | 920,683 | - |
| 400 | ALDX | Aldeyra Therapeutics, Inc. | 72.69M | -1.23% | 644,707 | - |
| 401 | OKYO | OKYO Pharma Limited | 72.42M | 0.36% | 87,733 | - |
| 402 | SPRO | Spero Therapeutics, Inc. | 71.63M | -1.60% | 542,768 | 47.00M |
| 403 | CING | Cingulate Inc. | 70.24M | -4.55% | 149,484 | - |
| 404 | KLRS | Kalaris Therapeutics, Inc. | 69.51M | -4.89% | 49,251 | - |
| 405 | CSBR | Champions Oncology, Inc. | 68.20M | -1.01% | 8,796 | 60.66M |
| 406 | CNTB | Connect Biopharma Holdings Limited | 68.01M | -1.82% | 803,829 | 2.95M |
| 407 | PLRX | Pliant Therapeutics, Inc. | 66.88M | -5.26% | 450,184 | - |
| 408 | GOSS | Gossamer Bio, Inc. | 66.85M | 0.09% | 426,556 | 53.29M |
| 409 | XBIT | XBiotech Inc. | 66.16M | 0.46% | 10,825 | - |
| 410 | ALPS | Alps Group Inc | 65.89M | -1.00% | 69,697 | 3.74M |
| 411 | HYFT | MindWalk Holdings Corp. | 65.01M | 1.47% | 140,491 | 11.57M |
| 412 | RNTX | Rein Therapeutics Inc. | 64.56M | 0.59% | 112,759 | - |
| 413 | ATHE | Alterity Therapeutics Limited | 64.32M | -2.65% | 2,530 | 2.50M |
| 414 | HYPD | Hyperion DeFi, Inc. | 62.78M | -3.12% | 584,948 | 1.40M |
| 415 | INKT | MiNK Therapeutics, Inc. | 62.15M | -0.98% | 11,487 | - |
| 416 | CLNN | Clene Inc. | 61.12M | 2.14% | 136,464 | 197.00K |
| 417 | ELOX | Eloxx Pharmaceuticals, Inc. | 60.67M | -6.06% | 27,603 | - |
| 418 | BOLD | Boundless Bio, Inc. | 60.51M | 2.31% | 255,081 | - |
| 419 | XLO | Xilio Therapeutics, Inc. | 59.48M | -0.11% | 3,298 | 64.09M |
| 420 | MREO | Mereo BioPharma Group plc | 59.09M | 9.63% | 2,095,430 | 500.00K |
| 421 | EXOZ | eXoZymes, Inc. | 57.96M | -1.50% | 9,188 | -700.00 |
| 422 | INMB | INmune Bio Inc. | 56.34M | 1.50% | 196,145 | 50.00K |
| 423 | HRTX | Heron Therapeutics, Inc. | 55.85M | 1.45% | 1,568,838 | 151.18M |
| 424 | ANVS | Annovis Bio, Inc. | 55.81M | -1.50% | 573,556 | - |
| 425 | EDSA | Edesa Biotech, Inc. | 54.18M | -0.50% | 16,764 | - |
| 426 | IMA | ImageneBio, Inc. | 53.58M | 1.29% | 17,832 | 800.00K |
| 427 | SER | Serina Therapeutics, Inc. | 53.09M | -2.34% | 29,447 | 130.00K |
| 428 | APLM | Apollomics, Inc. | 49.08M | -4.81% | 39,569 | 8.84M |
| 429 | LITS | Lite Strategy, Inc. | 49.00M | 0.70% | 2,270,193 | - |
| 430 | TIL | Instil Bio, Inc. | 48.63M | -0.42% | 9,505 | - |
| 431 | IBO | Impact BioMedical Inc. | 48.61M | 0.71% | 20,645 | 35.00K |
| 432 | ELTX | Elicio Therapeutics, Inc. | 48.36M | -2.13% | 165,269 | - |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 46.65M | -2.15% | 454,528 | 21.00M |
| 434 | DWTX | Dogwood Therapeutics, Inc. | 46.23M | -4.90% | 46,396 | - |
| 435 | PDSB | PDS Biotechnology Corporation | 44.61M | -0.37% | 3,937,366 | - |
| 436 | GRCE | Grace Therapeutics, Inc. | 44.60M | -1.85% | 80,175 | - |
| 437 | MGX | Metagenomi Therapeutics, Inc. | 43.44M | - | 70,806 | 13.56M |
| 438 | VERU | Veru Inc. | 43.31M | 1.20% | 116,069 | 16.89M |
| 439 | CELU | Celularity Inc. | 39.95M | 4.55% | 166,069 | 26.55M |
| 440 | CRVO | CervoMed Inc. | 38.40M | 0.79% | 106,053 | 331.30K |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 37.73M | 0.84% | 28,418 | 35.09M |
| 442 | IMMP | Immutep Limited | 37.26M | 0.57% | 665,104 | 13.79M |
| 443 | BCTX | BriaCell Therapeutics Corp. | 37.17M | 0.82% | 139,993 | - |
| 444 | KPTI | Karyopharm Therapeutics Inc. | 36.74M | -6.36% | 1,466,891 | 146.62M |
| 445 | FLNA | Filana Therapeutics, Inc. | 36.14M | -3.20% | 779,522 | - |
| 446 | MCRB | Seres Therapeutics, Inc. | 34.99M | -2.76% | 55,674 | 1.88M |
| 447 | ALGS | Aligos Therapeutics, Inc. | 34.41M | -0.72% | 45,046 | 31.52M |
| 448 | NNVC | NanoViricides, Inc. | 32.80M | - | 413,371 | - |
| 449 | BYSI | BeyondSpring Inc. | 31.96M | 7.20% | 15,569 | 1.88M |
| 450 | CNTX | Context Therapeutics Inc. | 31.76M | -6.84% | 1,325,677 | - |
| 451 | QNCX | Quince Therapeutics, Inc. | 31.53M | 3.33% | 10,314 | - |
| 452 | QNTM | Quantum BioPharma Ltd. | 31.14M | -3.75% | 193,360 | - |
| 453 | QNRX | Quoin Pharmaceuticals, Ltd. | 30.89M | 0.78% | 11,264 | - |
| 454 | LONA | LeonaBio, Inc. | 30.62M | -34.87% | 349,443 | - |
| 455 | ATYR | aTyr Pharma, Inc. | 29.92M | -9.66% | 8,360,425 | 190.00K |
| 456 | CVM | CEL-SCI Corporation | 29.37M | -2.91% | 36,410 | - |
| 457 | ABVC | ABVC BioPharma, Inc. | 29.29M | 3.67% | 89,253 | 797.92K |
| 458 | IGC | IGC Pharma, Inc. | 29.20M | 0.46% | 684,236 | 1.11M |
| 459 | RNAZ | TransCode Therapeutics, Inc. | 28.61M | 2.42% | 14,739 | - |
| 460 | KYNB | Kyntra Bio, Inc. | 28.10M | -0.86% | 19,745 | 4.62M |
| 461 | EVAX | Evaxion A/S | 27.86M | 2.45% | 44,955 | 7.49M |
| 462 | PLRZ | Polyrizon Ltd. | 25.88M | 2.52% | 980 | - |
| 463 | RADX | Radiopharm Theranostics Limited | 24.37M | 4.96% | 37,794 | 9.34M |
| 464 | GRDX | GridAI Technologies Corp. | 24.29M | -9.97% | 134,381 | - |
| 465 | NXTC | NextCure, Inc. | 23.25M | -3.79% | 71,790 | - |
| 466 | TCRX | TScan Therapeutics, Inc. | 23.04M | -2.58% | 382,314 | 7.11M |
| 467 | COCP | Cocrystal Pharma, Inc. | 22.54M | 1.74% | 13,381 | 330.00K |
| 468 | PBM | Psyence Biomedical Ltd. | 21.21M | -5.12% | 110,544 | - |
| 469 | ESLA | Estrella Immunopharma, Inc. | 20.92M | 2.12% | 28,054 | - |
| 470 | JSPR | Jasper Therapeutics, Inc. | 20.27M | 4.05% | 163,087 | - |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 19.75M | - | 1,323 | 1.17M |
| 472 | MRKR | Marker Therapeutics, Inc. | 19.17M | -3.36% | 30,647 | 3.55M |
| 473 | AKTX | Akari Therapeutics, Plc | 18.99M | -3.03% | 71,534 | - |
| 474 | ATOS | Atossa Therapeutics, Inc. | 18.96M | -7.32% | 77,843 | - |
| 475 | LPCN | Lipocine Inc. | 17.31M | 0.48% | 32,708 | 1.57M |
| 476 | NCEL | NewcelX Ltd. | 17.02M | 1.96% | 4,772 | - |
| 477 | CLRB | Cellectar Biosciences, Inc. | 17.01M | -13.25% | 124,577 | - |
| 478 | TVRD | Tvardi Therapeutics, Inc. | 16.94M | 19.81% | 658,217 | - |
| 479 | KPRX | Kiora Pharmaceuticals, Inc. | 16.74M | -2.62% | 2,094 | 20.00K |
| 480 | KTTA | Pasithea Therapeutics Corp. | 16.68M | -2.82% | 94,760 | - |
| 481 | PTN | Palatin Technologies, Inc. | 16.60M | 4.36% | 22,381 | 12.88M |
| 482 | ALLR | Allarity Therapeutics, Inc. | 16.39M | -5.50% | 43,661 | 345.00K |
| 483 | ACTU | Actuate Therapeutics, Inc. | 16.33M | 9.68% | 383,380 | - |
| 484 | BCDA | BioCardia, Inc. | 15.90M | -1.87% | 53,781 | 3.00K |
| 485 | CTXR | Citius Pharmaceuticals, Inc. | 15.88M | 1.47% | 65,157 | 7.11M |
| 486 | CMMB | Chemomab Therapeutics Ltd. | 15.65M | -1.82% | 63,239 | - |
| 487 | LTRN | Lantern Pharma Inc. | 15.60M | 0.83% | 220,432 | - |
| 488 | PASG | Passage Bio, Inc. | 15.45M | - | 8,690 | - |
| 489 | DYAI | Dyadic International, Inc. | 15.16M | -4.41% | 141,748 | 3.80M |
| 490 | CNSY | Cerenome, Inc. | 15.10M | 6.42% | 204,229 | 4.20M |
| 491 | ICU | SeaStar Medical Holding Corporation | 15.07M | -0.58% | 29,962 | 1.71M |
| 492 | HIND | Vyome Holdings, Inc. | 14.32M | -0.97% | 9,302 | 129.73K |
| 493 | LSTA | Lisata Therapeutics, Inc. | 14.24M | 3.33% | 47,443 | 100.00K |
| 494 | NIKI | Niki BioSolutions, Inc. | 13.99M | -4.23% | 58,369 | - |
| 495 | TPST | Tempest Therapeutics, Inc. | 13.71M | -2.47% | 288,317 | - |
| 496 | AEON | AEON Biopharma, Inc. | 13.15M | 1.31% | 566,522 | - |
| 497 | NRSN | NeuroSense Therapeutics Ltd. | 12.85M | -6.08% | 6,800 | - |
| 498 | PLUR | Pluri Inc. | 12.47M | -3.81% | 5,056 | 1.02M |
| 499 | GTBP | GT Biopharma, Inc. | 12.43M | 0.88% | 79,842 | - |
| 500 | INTS | Intensity Therapeutics, Inc. | 12.41M | -2.31% | 8,415 | - |